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Commentary
The possibility that radiation releases from 
nuclear facilities could cause cancer in sur­
rounding populations has been of interest for 
more than two decades. Epidemiologic studies 
of spatial variation in cancer incidence or mor­
tality have been conducted to investigate effects 
of unplanned releases as well as routine opera­
tions. For example, a case–control study of 
cancer among children < 5 years of age found 
that residence within 5 km of a nuclear facility 
was associated with a 61% [one­sided lower 
bound of the 95% confidence interval (CI), 
26%] increased incidence of all cancer (Spix 
et al. 2008) and a 119% (lower bound of the 
95% CI, 51%) excess risk of leukemia (Kaatsch 
et al. 2008a). A meta­analysis of geographic 
studies reported 23% (95% CI, 7–40%) 
higher incidence of leukemia among children 
0–9 years of age living within 16 km of nuclear 
facilities (Baker and Hoel 2007). Other studies 
have compared risks among populations whose 
radiation doses have been estimated based on 
releases and transport of radiation or deposi­
tion of radio  nuclides. A study of thyroid disease 
among people who were exposed to radio  active 
iodine from the Hanford site in Washington 
State found that the risk of thyroid disease was 
similar regardless of the estimated doses from 
radio  iodine (Davis et al. 2004), whereas a study 
of childhood leukemia after the Chernobyl 
accident, which classified radiation doses based 
on soil radio  activity and diet, reported an excess 
relative risk per gray of radiation of 32.4 (95% 
CI, 8.8–84.0) (Davis et al. 2006).
In April 2010 the U.S. Nuclear Regulatory 
Commission (NRC) asked the National 
Academy of Sciences (NAS) to analyze “radio­
genic cancer mortality and total cancer mortal­
ity in populations living near past, present, 
and possible future commercial nuclear facili­
ties for all age groups,” and to conduct the 
same analyses for cancer incidence (Sheron 
2010). Nuclear power, weapons, and fuel­cycle 
plants are to be included. Before beginning 
the full study in late 2011, the NAS is to con­
duct a scoping study to determine availability 
of data, feasibility of considering geographic 
units smaller than counties, and the best study 
design for assessing risks. The NRC request 
underscores the need to evaluate logical prob­
lems with previous studies of cancer around 
nuclear facilities and to consider the appro­
priateness of specific hypotheses and design 
options. In the United States these issues are of 
interest, in part, because of continued nuclear 
weapons production and federal support for 
construction of new nuclear power plants.
Currently, the NRC relies on a 1990 report 
from the National Cancer Institute (NCI 
1990) as its primary source for information 
about cancer risk from nuclear facilities (NRC 
2010). That study compared cancer death rates 
in 107 counties that either contained, or neigh­
bored a county that contained, a nuclear facil­
ity, with rates in 292 matched counties. For 
the period 1950–1984, investigators enumer­
ated approximately 900,000 cancer deaths in 
nuclear facility counties and 1.8 million deaths 
in matched counties. A study of cancer inci­
dence was restricted to Iowa and Connecticut, 
states that included four nuclear facilities. 
Jablon et al. (1991) summarized the findings 
from this study and concluded that “if nuclear 
facilities posed a risk to neighboring popula­
tions, that risk was too small to be detected by 
a survey such as this one.”
The NRC request for an “update” of the 
NCI study requires that NAS wrestle with 
several logical and methodological problems 
that have plagued the literature on cancer 
risks around nuclear facilities. Here we iden­
tify some key issues that must be addressed 
in order for the new study to advance science 
more than public relations.
Hypothesis Formation 
and Research Design in 
Epidemiology
General versus specific causation. Most epi­
demiologic studies investigate general expo­
sure–response relationships; neither the 
source of exposure nor a particular popula­
tion is of interest. A major consideration in 
such studies is that exposures and responses 
can be measured accurately. Populations that 
have been enumerated to evaluate the ques­
tion of radiation and cancer include A­bomb 
survivors whose doses were estimated as a 
function of distance from hypocenter and 
shielding, patients exposed to medical or diag­
nostic radia  tion procedures recorded in clini­
cal records, and workers whose occupational 
exposures have been monitored by individual 
dosimeters (National Research Council 2006). 
Results from general causation studies are 
often used to estimate risks in specific popula­
tions that have not, or cannot, be studied.
Other epidemiologic studies are designed 
to evaluate specific causation relevant to par­
ticular people, places, and times. Although 
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hypotheses in these studies rely on knowledge 
of general causation, they aim to address the 
causes of disease in a particular population or 
similar populations. The question of cancer 
risks near nuclear facilities is specific because 
it concerns people who live near this category 
of facilities rather than the general exposure–
response association for ionizing radiation 
and cancer. An even more specific question 
is about cancer risks near a particular nuclear 
facility (e.g., Hoffmann et al. 2007). The speci­
ficity of these questions necessitates focusing 
on one nuclear facility or groups of facilities 
even if quantifying exposures and responses in 
neighboring populations is difficult.
Design of epidemiologic studies. Although 
usually nonexperimental, most epidemiologic 
studies are based on the model of an experi­
ment in which subjects are randomized to 
be exposed or not, and all other conditions 
are kept identical in the two groups, includ­
ing the assessment of responses. Although it 
is not necessary to know the mechanisms by 
which the exposure produces the response, 
knowledge about mechanisms is important 
for choosing factors to measure, measuring 
them correctly, and deciding the extent to 
which results support the hypothesis that the 
exposure causes the response. As in an experi­
ment, sample size must be chosen so that the 
response occurs with sufficient frequency to 
permit comparison of the groups.
However, because exposures cannot be 
randomized in nonexperimental studies, large 
sample size does not provide confidence that 
other conditions that influence the response 
are similarly distributed in the exposed and 
unexposed groups, and these potential con­
founders must be considered in the data 
analy  sis and interpretation of results. Studies 
of cancer risks around nuclear facilities typi­
cally adjust for demographic factors that may 
differ between nearby populations and groups 
to which they are compared but do not collect 
information on other potential confounders.
Descriptive versus analytic studies. Studies 
of disease trends and spatial patterns that do 
not focus on a specific etiologic agent are some­
times referred to as descriptive studies. Authors 
of some papers about cancer risks near nuclear 
facilities have labeled their studies descriptive, 
implying that they do not address a hypothe  sis 
(Laurier and Bard 1999; Laurier et al. 2008). 
However, studies of disease in populations sur­
rounding a specific type of facility are of inter­
est only if something released by that type of 
facility could cause the disease. Cancer risks 
near nuclear facilities are only of scientific 
interest because these facilities emit radiation 
and because ionizing radiation causes cancer. 
Calling a study descriptive does not remove the 
rationale for its conduct or reduce the impor­
tance of creating testable hypotheses about 
exposure and risk.
Assumptions Required 
for Testable Hypotheses
An epidemiologic hypothesis might be that 
the response is higher in the exposed than the 
unexposed group. However, the scientific value 
of the hypothesis is not merely numerical; it 
depends on assumptions about the level of 
the exposure, the shape and magnitude of the 
exposure–response relationship, and the sample 
size, all of which affect the study power.
Dose assumptions. A testable hypothesis 
requires a nontrivial difference in exposure 
between the groups being compared; the 
magnitude of difference that is nontrivial is a 
function of the dose response. Some studies of 
cancer around nuclear facilities have been con­
ducted under the assumption that the exposure 
is too low to cause the response. For example, 
Jablon et al. (1991) quote U.K. researchers: 
“The increased occurrence of cancers in per­
sons living near nuclear facilities could not 
have resulted from radio  active emissions from 
the facilities” because the doses were too low. 
Hatch et al. (1990) reported elevated cancer 
incidence in downwind areas after the 1979 
radiation releases from the Three Mile Island 
unit 2 reactor but went on to study stress as 
an alternative explanation (Hatch et al. 1991) 
because radiation doses were “a fraction of the 
average U.S. exposure.” Kaatsch et al. (2008a), 
who reported elevated childhood cancer risk 
near German nuclear facilities, concluded, 
“The observed positive distance trend remains 
unexplained,” noting that “radiation exposure 
near German nuclear power plants is a fac­
tor of 1,000–100,000” below background. 
In a technical report they state that radiation 
must be excluded as a cause of the observed 
dose–response relationship on “fundamental 
grounds” (Kaatsch et al. 2008b).
All these authors assumed that radiation 
exposures were too small to cause a response. 
They did not expect to find positive relation­
ships (Kaatsch et al. 1998). When they did, 
they could not conclude that the evidence 
supported rejection of the null hypothesis. 
British epidemiologist Geoffrey Rose described 
this situation in the Sellafield inquiry in the 
United Kingdom: “We were given informa­
tion (which, it later transpired, was incorrect) 
of the total radio  active emissions from the 
plant, but the exposure levels of the children 
were a matter of speculation. The radiation 
experts on the committee calculated ‘best 
estimates’ and they concluded, on theoretical 
grounds, that these could not have caused any 
major excess risk: ‘It couldn’t have happened, 
so it didn’t happen’” (Rose 1991).
Assumptions about doses to populations 
near nuclear facilities are based on estimated 
releases, environmental dispersion, human 
uptake, and estimates of the relative biological 
effectiveness of different forms of radiation. 
Except in the case of short­term exposures 
during an accident, environmental assump­
tions involve average emission estimates, dis­
tances from facilities, and sometimes prevailing 
winds. Most epidemiologic studies of popula­
tions near nuclear facilities have not considered 
the spatial pattern of ingestion of radio  nuclides 
from food or water, nor have they measured 
radiation doses to individuals. All have been 
based on emission estimates that come from 
industries responsible for the releases and   
agencies responsible for regulating them.
Dose–response assumptions. The con­
sequence of assumptions about dose levels 
depends on another assumption, the dose 
response: the increase in cancer for each unit 
increase in radiation dose. When excess cancer 
near nuclear facilities cannot be interpreted as 
evidence of an effect of releases, it is because 
the expected response from the estimated dose 
is too small to detect. For example, authors of 
the Three Mile Island study cited an aver­
age whole­blood gamma dose in the range of   
0.1–0.25 mSv in the 5­mile area around the 
plant (Hatch et al. 1990). The expected rela­
tive risk of cancer at this dose level, according 
to NAS BEIR V (Biological Effects of Ionizing 
Radiation, Health Effects of Exposure to Low­
Level Ionizing Radiation) (National Research 
Council 1990) estimates available around the 
time of the study, which were primarily based 
on studies of acute penetrating radiation 
exposures of A­bomb survivors, would be less 
than 1.0005. Unless the dose estimates, the 
dose–response estimates, or both were consid­
ered to be questionable, and by a combined 
factor of orders of magnitude, no results from 
the study could have been interpreted as sup­
porting the hypothesis that emissions caused 
cancer (Wing et al. 1997).
Past debate about obstetric X rays and 
childhood cancer illustrates the potential 
problem of overconfidence in the state of 
knowledge about a dose–response relation­
ship. Although it is now widely assumed that 
the effect of fetal irradiation on childhood 
cancer risk is orders of magnitude higher (on 
a relative risk scale) than the effect of adult 
exposure (Wakeford 2008), early evidence 
that obstetric X rays cause childhood cancer 
(Stewart et al. 1956) was rejected, primarily 
based on studies of acute penetrating radia­
tion exposures of A­bomb survivors. The Life 
Span Study of A­bomb survivors is impor­
tant because of its large size and inclusion of 
females and males of all ages. However, the 
cohort was assembled 5 years after exposure, 
and cancer incidence data are not available 
until 12 years after exposure. There are no 
data for early childhood, the time period of 
most interest in studies of cancer risk near 
nuclear facilities. Difficulties of quantify­
ing impacts of selective survival, dose mis­
classification, residual radiation, fallout, 
and other possible confounding factors on Cancer risks near nuclear facilities
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dose–response estimates suggest that caution 
should be used in extrapolating studies of 
acute radiation exposures in the Life Span 
Study to populations near nuclear facilities 
that may be chronically exposed to inhaled or 
ingested radio  nuclides.
Study power: sample size and measure-
ment of exposure and outcomes. The power 
or sensitivity of a study depends on the mag­
nitude of the effect, the sample sizes in the 
exposure groups, and the ability to accurately 
measure exposures and outcomes. The weaker 
the relationship, the larger the sample size 
needed to detect it. If the effect of exposure 
is small, combining populations near mul­
tiple U.S. nuclear facilities is important for 
a study of cancer risks near nuclear facilities. 
However, if an exposure–response relation­
ship does exist, it will be underestimated and 
may not be detected at all if people in the 
exposed and unexposed groups are mixed 
together. Large sample size is important, but 
when large sample size comes with poor expo­
sure classification, the consequence is a statis­
tically precise, biased estimate of effect.
Similarly, inability to track the response 
creates low study power. Assessment of can­
cer incidence (diagnosis) rather than death is 
important because many patients do not die 
of their cancers, and because the time between 
diagnosis and death increases the opportu­
nity for people to move between communities 
with and without nuclear facilities (sometimes 
as a result of their diagnosis). However, the 
lack of cancer registries with catchment areas 
covering populations residing near most U.S. 
nuclear facilities during their entire operating 
history presents a serious barrier to studying 
risks for all facilities during their entire periods 
of operation.
Next Steps in Research on 
Cancer Risks near Nuclear 
Facilities
Many studies of cancer near nuclear facili­
ties have been conducted since the 1990 
NCI study. An update of that study should 
build on what has been learned. Two recent 
childhood cancer studies have relatively large 
sample sizes: the meta­analysis of childhood 
leukemia in proximity to nuclear facili­
ties conducted by Baker and Hoel (2007) 
and the Kinderkrebs in der Umgebung 
von Kernkraftwerken (KiKK) case–control 
study of childhood leukemia (Kaatsch et al. 
2008a, 2008b) and childhood cancer (Spix 
et al. 2008) in the vicinity of German nuclear 
facilities. These studies are of particular inter­
est because of the high radio  sensitivity of the 
embryo, fetus, and infant, the use of inci­
dence rather than mortality data, and the 
ability to discriminate populations in close 
proximity to nuclear reactors (Fairlie 2009a, 
2009b, 2010; Nussbaum 2009). After intake, 
two radio  nuclides emitted by nuclear reactors, 
3H (tritium in the form of heavy water) and 
14C, are distributed throughout the body, and 
concentrations are 50–60% higher in fetal 
than in maternal tissues (Stather et al. 2002). 
Nuclear reactors routinely emit tritium and 
14C, and spikes are observed during refueling 
(Fairlie 2010). From these observations, we 
suggest several key considerations for research 
on cancer risks near U.S. nuclear facilities.
Exposure assessment. Studies of cancer risks 
around nuclear facilities under routine opera­
tions have focused on distance of residence 
from the facilities as the primary measure of 
exposure. Baker and Hoel (2007) focused 
on populations within 16 km (10 miles) 
of nuclear facilities. Studies based on large 
administrative districts, such as U.S. counties, 
including the 1990 NCI study (Jablon et al. 
1991), do not have sufficient spatial specificity 
to produce meaningful findings.
The KiKK study compared the distance 
from the nearest nuclear facility of the resi­
dences of childhood cancer cases at the time 
of diagnosis and distances of residences of 
disease­free controls in high geographic reso­
lution (100 m) (Kaatsch et al. 2008a; Spix 
et al. 2008). KiKK researchers analyzed risk as 
a continuous function with an a priori model 
of the reciprocal of distances ≤ 70 km, but the 
effects primarily reflect excesses in the vicinity 
of approximately 10 km of nuclear facilities. 
Several authors have emphasized the KiKK 
study’s precise distance measures as an advan­
tage of the study (Fairlie 2010; Nussbaum 
2009). Although such precision is desirable, 
the KiKK study did not analyze residence at 
birth or conception, which would be more 
relevant to fetal dose, nor did it evaluate resi­
dential history from conception to diagnosis, 
which would be relevant to exposure history. 
Other case–control studies should be designed 
to obtain such information.
However, residential distance is not a meas­
ure of dose, nor is it a good proxy unless all 
nuclear facilities have the same quantities and 
types of releases, pregnant mothers and chil­
dren stay at home all the time, house construc­
tion and time outdoors do not affect exposure, 
and wind direction and diet are unimportant. 
These factors could be considered by conduct­
ing dose reconstructions based on environ­
mental data for each facility and behavioral 
data from the populations being studied. This 
type of approach has been taken to a greater or 
lesser extent in some studies of single facilities 
(Davis et al. 2004, 2006; Hatch et al. 1990), 
but great effort and adequate data would be 
required to make such assessments for many 
facilities over long periods of time. An alter­
native strategy would be to classify exposure 
based on residential histories and to use mixed 
regression models to model the interfacility 
variability in distance–cancer relationships.
Measuring exposure during the correct 
time period is critical. Studies of young chil­
dren have an advantage in this regard because 
the lag time between exposure and diagnosis 
of cancer is restricted compared with adults 
and there is less opportunity for children to 
change residences. Especially in studies of 
childhood cancer, the operations history of 
a facility must be considered. For example, 
a child diagnosed with cancer at 4 years of 
age who lived near a nuclear power plant that 
began operations 2 years earlier could not have 
experienced in utero exposure to emissions 
from that plant. Similarly, air emissions from 
an operating reactor could not affect a child 
diagnosed at 4 years of age if the plant ceased 
operation 5 years earlier, but drinking water 
contaminated by radio  nuclides with sufficient 
half­lives could be important from conception 
through the date of diagnosis. These scenarios 
underscore the need to consider time periods 
of operation, releases, environmental path­
ways, uptake, and internal doses, including 
the physical half­lives, environmental trans­
formations, and biokinetics of radio  nuclides 
of interest. Such efforts have been made for 
studies of cancer risks near Chernobyl and 
Hanford (Davis et al. 2004, 2006), although 
not without problems (Hoffman et al. 2007).
Outcome assessment. Studies of cancer risks 
near nuclear facilities should rely on incidence 
data; however, only mortality data are available 
nationally for the locations and time periods   
of operation of all nuclear facilities in the 
United States. Unlike some countries where 
this research question has been addressed, the 
United States lacks a medical insurance sys­
tem that could be used to track cancer inci­
dence nationally. States have instituted cancer 
registries at different times and with varying 
degrees of regional coverage and quality. A new 
study should be restricted to locations and time 
periods for which adequate cancer incidence 
data can be assembled. Additionally, because 
the ability to ascertain incident cancers among 
people who live near nuclear facilities declines 
with time and movement outside areas covered 
by state cancer registries, the short exposure lag 
for children improves the prospects for com­
plete ascertainment of childhood cancers.
Dose response. The inability of previous   
investigators to interpret positive findings as 
evidence in support of the hypothesis under 
investigation results, in part, from the belief 
that the dose response is too small to be 
detectable. One remedy for this problem is to 
select a sensitive subpopulation for investiga­
tion. In their meta­analysis, Baker and Hoel 
(2007) included only populations < 25 years 
of age, and they focused on children 
< 10 years of age. The KiKK study includes 
only children < 5 years of age. The focus on 
young ages is justified because of theory and 
evidence of greater risks from in utero and Wing et al.
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childhood than adult exposures, and because 
previous studies have found the strongest 
associations for children.
Sample size. Childhood cancer occurs 
infrequently, so nuclear facilities with few 
children nearby cannot contribute many cases 
to an epidemiologic study. However, popula­
tion size has little effect on the effort required 
to evaluate historical releases and environ­
mental pathways. The most efficient expen­
diture of time and money would be to give 
priority to inclusion of facilities with larger 
nearby populations. Although population size 
is an important consideration, selection of 
facilities with larger nearby populations could 
be problematic if it led to systematic exclu­
sion of facilities with larger estimated releases 
(Körblein and Hoffmann 1999).
Potential confounders. Other causes of 
cancer could bias estimates of cancer risk 
from nuclear facilities if they are more or less 
common among populations around nuclear 
facilities than in comparison populations. One 
advantage of restricting a study to children 
is that they are less exposed to potentially 
confounding occupational and lifestyle car­
cinogens than are adults. Although the KiKK 
study did not achieve a high enough response 
rate among control children to use data on 
other cancer risk factors in primary analyses, 
ambient pesticide exposure, medical X rays 
(child and mother, diagnostic and therapeutic), 
fertility treatment, infections, medical drugs 
during pregnancy, and hair dye use were not 
associated with distance from nuclear power 
plants (Kaatsch et al. 2008b). Measurements 
of medical radiation, other sources of radiation, 
or other carcinogenic exposures, even if they 
are obtained from independent surveys, could 
be used to evaluate whether these factors are 
strongly enough correlated with nuclear facili­
ties to result in an appreciable bias that could 
create or mask distance–cancer relationships 
observed in an epidemiologic study.
Although not yet identified, viruses may 
play a role in the development of childhood 
leukemia. Studies of time in day care during 
infancy, a measure of potential viral exposure, 
show protective effects for childhood leukemia 
(Petridou et al. 1993; Urayama et al. 2008), 
whereas studies of in­migration to rural areas, 
another possible source of viral exposure, sug­
gest that population mixing increases risk 
(Kinlen et al. 1995; Wartenberg et al. 2004). 
A case–control study could obtain history of 
day­care exposures, and in­migration could 
be evaluated in either a case–control or area­
based design.
Another method of evaluating confound­
ing is to measure cancer incidence near nuclear 
facilities during the time period preceding 
startup. If one or more confounding factors, 
known or unknown, is associated with prox­
imity, a relationship between proximity and 
cancer would be observed before startup. The 
prestartup dose–response estimate, which 
quantifies the degree of confounding under 
the assumption that the spatial distribution of 
the confounding factors is the same before and 
after startup, can then be subtracted from the 
poststartup dose response to control this source 
of bias (Hatch et al. 1990; Wing et al. 1997).
A Bayesian perspective. One way to mini­
mize problems of circular logic in the inter­
pretation of epidemiological results (the null 
hypothesis cannot be rejected because we 
assume the exposure was too small to cause an 
effect), and to better inform power calculations 
for any future study, is to encourage investiga­
tors to explicitly state their prior beliefs. In a 
Bayesian framework, assumptions about dose 
and dose response are made explicit in prior 
distributions and then updated based on new 
evidence. If the investigators hold strong prior 
beliefs about the magnitudes of dose and the 
dose effects, then it may be helpful to recognize 
at the outset that a proposed study may have 
little ability to shift posterior estimates of effect. 
Then researchers could avoid conducting stud­
ies that have little ability to affect strong prior 
convictions about the association of interest.
Conclusions
The NRC has asked the NAS to study mor­
tality from all types of cancer, cancer at all 
ages, and cancer at sites where nuclear facili­
ties might be licensed in the future. The con­
siderations reviewed here suggest that such an 
approach could lead to an excessive number 
of comparisons. Effects in subgroups of inter­
est could be discounted if considered in the 
context of a large number of extraneous com­
parisons. Fortunately, the NRC has also asked 
the NAS to evaluate radiation doses to off­
site populations and to recommend the best   
epidemiologic study design.
The only scientific reason to conduct studies   
of cancer around nuclear facilities is to evalu­
ate whether radiation doses to neighboring 
populations result in a detectable increase in 
cancer risk. It is not logical to test a hypothesis 
of elevated cancer near facilities if it is decided 
a priori that results cannot be interpreted as 
evidence in support of the hypothesis. Such 
an exercise would amount to a public rela­
tions effort masquerading as a scientific study. 
Authors of a study of doses from the 1979 
radiation releases at Three Mile Island were 
explicit about the intent of their methodology, 
which they described as having been devel­
oped “for educational, public relations and 
defensive epidemiology purposes” (Gur et al. 
1983). This is apparently the scenario that is 
envisioned by Ralph Andersen of the Nuclear 
Energy Institute in reference to the NRC’s 
request to the NAS: “These types of studies 
simply cannot even imply causality, and I 
would be disappointed if this study undertook 
to believe that it was a study of causality” 
[Andersen 2010; see Supplemental Material 
for audio recording of the 15th meeting of 
the Nuclear and Radiation Studies Board of 
the National Academies, Washington, DC, 
26 April 2010 (doi:10.1289/ehp.1002853)].
On the contrary, we believe the only rea­
son to conduct a study is to address causal 
hypotheses regarding cancer risks near nuclear 
facilities. To preserve the integrity of scientific 
research in this area, there must be careful 
engagement with issues of the physical and 
biological mechanisms of interest and selec­
tion of populations for study based on the 
ability to obtain adequate measurements and 
sample sizes.
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